SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001193125-10-160270
Filing Date
2010-07-16
Accepted
2010-07-16 17:14:59
Documents
13

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM 10 d1012ga.htm 10-12G/A 1407460
2 SERVICES AGREEMENT BETWEEN NEOGENIX AND SELEXIS SA DATED AUGUST 12, 2009 dex1028.htm EX-10.28 484855
3 SERVICES AGREEMENT BETWEEN NEOGENIX AND SELEXIS SA DATED APRIL 12, 2010 dex1029.htm EX-10.29 504427
4 SERVICES AGREEMENT BETWEEN NEOGENIX AND SELEXIS SA DATED APRIL 12, 2010 dex1030.htm EX-10.30 513878
6 GRAPHIC g74226g48c55.jpg GRAPHIC 29415
7 GRAPHIC g74226img001.jpg GRAPHIC 57353
8 GRAPHIC g74226img002.jpg GRAPHIC 60093
9 GRAPHIC g74226img003.jpg GRAPHIC 54951
10 GRAPHIC g74226img004.jpg GRAPHIC 91282
11 GRAPHIC g74226img1.jpg GRAPHIC 13481
12 GRAPHIC g74226img2.jpg GRAPHIC 12744
13 GRAPHIC g74226img3.jpg GRAPHIC 9805
14 filename14.htm CORRESP 9191
  Complete submission text file 0001193125-10-160270.txt   3375851
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-12G/A | Act: 34 | File No.: 000-53963 | Film No.: 10957056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances